Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
492,937,031
-
Number of holders
-
390
-
Total 13F shares, excl. options
-
369,452,160
-
Shares change
-
-2,366,472
-
Total reported value, excl. options
-
$10,879,469,608
-
Value change
-
-$57,025,660
-
Put/Call ratio
-
98%
-
Number of buys
-
191
-
Number of sells
-
-163
-
Price
-
$29.45
Significant Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) as of Q4 2019
464 filings reported holding ELAN - Elanco Animal Health Inc - COMMON STOCK as of Q4 2019.
Elanco Animal Health Inc - COMMON STOCK (ELAN) has 390 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 369,452,160 shares
of 492,937,031 outstanding shares and own 75% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (34,077,726 shares), PRICE T ROWE ASSOCIATES INC /MD/ (33,384,657 shares), WELLINGTON MANAGEMENT GROUP LLP (30,932,315 shares), PRIMECAP MANAGEMENT CO/CA/ (30,598,365 shares), BlackRock Inc. (19,452,458 shares), AMUNDI PIONEER ASSET MANAGEMENT INC (16,315,711 shares), Invesco Ltd. (14,198,702 shares), LAZARD ASSET MANAGEMENT LLC (14,193,741 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (10,568,487 shares), and STATE STREET CORP (10,167,561 shares).
This table shows the top 390 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.